Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00776126 · ClinicalTrials.gov registry record

Digital Breast Tomosynthesis Preference Study

A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
51
Enrollment target

NCT00776126 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00776126 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventional mammography is the presence of superimposed breast tissue that can obscure clinically significant lesions. It is this limitation that decreases the sensitivity of mammography and leads to false negative results. The recent development of digital detectors has allowed imaging technologies such as tomosynthesis to become clinically feasible. The examination, similar to conventional mammography with regard to patient positioning and glandular dose, allows acquisition of a digital data set that can be reconstructed and viewed in multiple sections. The ability of tomosynthesis to unmask overlapping structures has been shown in preliminary studies to increase lesion visibility. Used as either a primary imaging modality, or as an adjunct to screening mammography, tomosynthesis has the potential to provide increased sensitivity and a lower number of false negative examinations. The purpose of this study is to compare radiologist impression of digital breast tomosynthesis to digital mammography with respect to their ability to see and characterize specific lesion features.

Interventions

  • DEVICE Digital Breast Tomosynthesis Exam

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2008-10
Est. Completion 2010-06

What the Registry Record Tells You About NCT00776126

The ClinicalTrials.gov registry entry for NCT00776126 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Digital Breast Tomosynthesis Exam is the first listed.

NCT00776126 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00776126 about?

NCT00776126 is a clinical study titled "Digital Breast Tomosynthesis Preference Study". Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventional mammography is the presence of superimposed breast tissue that can obscure clinically significant lesions. It ...

What is the current status of trial NCT00776126?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2008-10. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00776126?

The interventions under investigation include: Digital Breast Tomosynthesis Exam (DEVICE).

Who is sponsoring clinical trial NCT00776126?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.